Nautilus Biotechnolgy, Inc. Common Stock

NAUTNASDAQ • USD
2.23 USD
↘ 0.10 (4.09%)🟢LIVE (AS OF 11:28 AM EST)
🟢Market: OPEN

Nautilus Biotechnolgy, Inc. Common Stock (NAUT) trades at $2.23 per share. Technicals currently rate "Neutral" while our fundamental analysis reads "Sell". Key drivers include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bearish Death Cross on the long-term moving averages. NAUT is fairly valued relative to its sector peers based on current multiples.

Technical & fundamental data as of Nov 13, 2026.

Open?$2.25
High?$2.38
Low?$2.13
Prev. Close?$2.32
Volume?1.4M
Avg. Volume?9.8M
VWAP?$2.19
Rel. Volume?0.14x
Bid / Ask
Bid?$2.21 × 1.3K
Ask?$2.22 × 900
Spread?$0.01
Midpoint?$2.22
Valuation & Ratios
Market Cap?295.5M
Shares Out?127.4M
Float?54.0M
Float %?42.4%
P/E Ratio?N/A
P/B Ratio?2.54
EPS?-$0.46
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome. The Company transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. Its products includes: Proteome Analysis System, Reagent Kits, Software and analysis.
Employees
130
Market Cap
295.5M
Industry
LABORATORY ANALYTICAL INSTRUMENTS
Listed
2021-06-10
Address
2701 EASTLAKE AVE EAST
SEATTLE, WA 98102
Phone: 206-333-2001
Technical OutlookNeutral
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+1/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
14
Momentum?
62
Short Sent.?
73
Piotroski F-Score?0/9Weak
Altman Z-Score?1.17Distress
Confidence?52%Low
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?10.81%High
Short Interest?5.8M
Days to Cover?1.0
Free Float54.0M
Avg Daily Volume11.6M
Settlement Date2026-10-30
Financial Health
Current Ratio?9.25Strong
Quick Ratio?9.25Strong
Cash Ratio?1.07Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
67/100
P/E?
N/A▾
P/B?
Peers
100
S&P
64
2.54CHEAP▾
P/S?
Peers
100
S&P
3
696.94HIGH▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-4.5CHEAP▾
EV/Sales?
Peers
100
S&P
3
672.26HIGH▾
Returns & Efficiency
ROE?
S&P
3
-50.3%WEAK▾
ROA?
S&P
3
-39.3%WEAK▾
Cash Flow & Enterprise
FCF?$-55135000
Enterprise Value?$285.0M
Fundamentals ratios updated end of day